Individualization of anticancer therapy; molecular targets of novel drugs in oncology

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

Deregulation of cellular signal transduction, caused by gene mutations, has been recognized as a basic factor of cancer initiation, promotion and progression. Thus, the ability to control the activity of overstimulated signal molecules by the use of appropriate inhibitors became the idea of targeted cancer therapy, which has provided an effective tool to normalize the molecular disorders in malignant cells and to treat certain types of cancer. The molecularly targeted drugs are divided into two major pharmaceutical classes: monoclonal antibodies and small-molecule kinase inhibitors. This review presents a summary of their characteristics, analyzing their chemical structures, specified molecular targets, mechanisms of action and indications for use. Also the molecules subjected to preclinical trials or phase I, II and III clinical trials evaluating their efficiency and safety are presented. Moreover, the article discusses further perspectives for development of targeted therapies focusing on three major directions: systematic searching and discovery of new targets that are oncogenic drivers, improving the pharmacological properties of currently known drugs, and developing strategies to overcome drug resistance. Finally, the role of proper pharmacodiagnostics as a key to rational anticancer therapy has been emphasized since the verification of reliable predictive biomarkers is a basis of individualized medicine in oncology.

Authors and Affiliations

Katarzyna Regulska, Beata Stanisz, Miłosz Regulski

Keywords

Related Articles

Molecular actions of 17β-estradiol and progesterone and their relationship with cellular signaling pathways

Sex steroids: 17β-estradiol and progesterone play a major role in modulation of reproductive functions of the organism and participate in regulation of a broad spectrum of cellular processes in target cells via their spe...

The role of intestinal microbiota in irritable bowel syndrome

In recent years, impressive advances in the knowledge about a vast number of microbes living in the human body and interactions between the microbiota and the human body have been observed. All micro-organisms that live...

Antyoksydacyjne właściwości hialuronianu wobec ludzkich neutrofilów zależą od jego masy cząsteczkowej i stężenia i są wywierane głównie w przestrzeni zewnątrzkomórkowej

Wstęp: Hialuronian (HA), składnik macierzy zewnątrzkomórkowej, poprzez interakcje z receptorami może regulować funkcje komórek odpornościowych. Poza wpływem na wytwarzanie cytokin i chemokin, opisano również jego właściw...

Między biologią a medycyną: perspektywy wykorzystania komórek dendrytycznych w terapii przeciwnowotworowej

Komórki dendrytyczne (DCs) tworząc połączenie między odpornością wrodzoną a nabytą, odgrywają istotną rolę w utrzymaniu homeostazy w układzie odpornościowym. Populację DCs cechuje heterogenność – w jej skład wchodzi wiel...

Download PDF file
  • EP ID EP66815
  • DOI -
  • Views 178
  • Downloads 0

How To Cite

Katarzyna Regulska, Beata Stanisz, Miłosz Regulski (2012). Individualization of anticancer therapy; molecular targets of novel drugs in oncology. Advances in Hygiene and Experimental Medicine, 66(0), 855-867. https://www.europub.co.uk/articles/-A-66815